Conference Coverage

New atopic dermatitis agents expand treatment options


 

REPORTING FROM THE CARIBBEAN DERMATOLOGY SYMPOSIUM

But no matter which therapy is chosen, regular moisturizing is critically important, Dr. Fowler remarked. Expensive prescription moisturizers are available, but he questioned whether they offer any cost-worthy extra benefit over a good nonprescription moisturizer.

“Do these super-moisturizers protect the skin barrier any more than petrolatum? I can’t answer that. They promise better results, but each patient and doc have to make the decision. If your patient can afford it, maybe some will be better for their skin, but really, it’s not as important as some of the other medications. So, I tell them, if cost is an issue, don’t worry about the fancy moisturizers.”

Dr. Fowler disclosed relationships with multiple pharmaceutical companies.

Global Academy and this news organization are owned by the same parent company.

Correction, 2/15/19: An earlier version of this article mischaracterized the chemical action of dupilumab.

Pages

Recommended Reading

Novel topical JAK inhibitor shows promise for atopic dermatitis
MDedge Dermatology
Review of pediatric data indicates link between vitamin D levels and atopic dermatitis severity
MDedge Dermatology
Allergy Testing in Dermatology and Beyond
MDedge Dermatology
Gestational, umbilical cord vitamin D levels don’t predict atopic disease in offspring
MDedge Dermatology
New worldwide atopic dermatitis survey brings big surprises
MDedge Dermatology
Fungal failure
MDedge Dermatology
Atopic dermatitis associated with increased suicidality
MDedge Dermatology
Danish study finds reassuring data on pregnancy outcomes in atopic dermatitis patients
MDedge Dermatology
Adult atopic dermatitis is fraught with dermatologic comorbidities
MDedge Dermatology
Novel atopic dermatitis cream shows promise in phase 2 study
MDedge Dermatology